Transforming growth factor-beta (TGF-beta) signaling is mediated from serine/threonine kinase receptors to transcriptional responses via Smad proteins. Here comparison of mRNA expression of Smad3±7 in mouse embryos (E9-E15) revealed developmentally regulated distinct expression patterns for Smad3, 4, 6, and 7. Smad3 was prominently expressed in the differentiating (from E10) central nervous system, but also in developing bones, branchial arches and epithelium of various tissues. Smad4 mostly showed ubiquitous expression, but in E15 embryos, a pronounced signal appeared in epithelial crypts of the gut. Inhibitory Smad6 and Smad7 were coexpressed at high levels in developing cardiovascular system from the earliest stages studied. In contrast, Smad6 was selectively expressed at high levels, e.g. in intramembranous bone whereas Smad7 was prominent in seminiferous tubules of the testis, demonstrating distinct expression of these genes in non-cardiovascular tissues. q
Results
Intracellular TGFb signals from transmembrane serine/ threonine kinase receptors to the nucleus are mediated by proteins encoded by the conserved Smad genes. Pathway restricted Smad1, Smad5, and Smad8 mediate BMP signaling, whereas TGFb signals are transduced by Smad2 and Smad3. Smad4 is a common partner for the pathwayrestricted Smads while inhibitory Smad6 and Smad7 function as antagonists for pathway speci®c Smads (reviewed in Miyazono et al., 2000) . There is increasing evidence that Smads exert speci®c regulatory functions during embryonic development. Targeted inactivation of Smad2, Smad4 and Smad5 results in embryonic lethality (Miyazono et al., 2000) whereas some Smad62/2 mice are viable, although exhibit cardiovascular defects (Galvin et al., 2000) . Expression patterns of Smad1, and Smad2 during mouse embryonal development have been thoroughly studied (Waldrip et al., 1998; Dick et al., 1998) . Characterization of Smad3±6 expression has been limited to single genes with speci®c tissues or embryonic stages (Zhu et al., 1998; Yang et al., 1998 Yang et al., , 1999 Chang et al., 1999; Galvin et al., 2000; Zwijsen et al., 2000) . Here we compared expression of Smad3±7 systematically between days 9 and 15 of embryogenesis.
During the embryonic stages studied, expression of both Smad4 and Smad5 was ubiquitous and largely correlated with cell density (Figs. 1 and 2) with some exceptions (see below).
Smad3 expression in neural tissues was mostly ubiquitous up to embryonic day 9 (Fig. 1B) . At E10 a diminished signal was noted in the marginal neuroepithelium of the neural tube (me in Fig. 1E ). At this stage high Smad3 was detected in the myeloncephalon, which later differentiates into the medulla oblongata (arrowhead in Fig. 1E ). At E12 Smad3 expression becomes restricted to the neuroepithelium lining the brain ventricles and the lumen of the spinal cord with prominent expression in the¯oor plate (fp in Fig. 2B ). At E15 Smad3 expression in the central nervous system is almost undetectable (not shown).
Also outside the nervous system, the ubiquitous Smad3 expression at E9 became more speci®c at E10 (Fig. 1B,E) . In E10±E12 embryos Smad3 was prominent in branchial arches (ba in Fig. 1E ) and ectodermal epithelia such as the surface ectoderm of developing skin, oral and nasal cavities (n in Fig. 2B ).Similarly, endodermal epithelia of the developing internal organs such as lung, ureter, and duodenum expressed Smad3 (lg, d, u in Fig. 2B ). Later at E13±E15, Smad3 expression was less pronounced in endodermal epithelia and instead prominent expression was noted in mesoderm and neural crest-derived tissues such as the developing bones (f in Fig. 3A) and stroma of the submandibular salivary gland (sg in Fig. 3A ).
Smad6 and Smad7 were coexpressed prominently in the developing cardiovascular system from the earliest stages studied ( Fig. 1D,F; Fig. 3E,F; Fig. 3B ) with high expression in atrioventricular cushion tissues, aorta and other major arteries in agreement with previous studies (Galvin et al., 2000; Zwijsen et al., 2000) . However, coexpression of Smad6 and Smad7 was detected in other tissues as well. At E12 speci®c co-expression was detected in the choroid plexuses, the pituitary gland, and the otic vesicle (cp, pg and o in Fig. 2E,F and not shown) and at E15 also in the epithelium of the cochlea (not shown). In the urinary system, Smad6 and Smad7 were absent from mesonephros but transcripts were present in metanephric kidney and urogenital sinus (shown for Smad6 as u in Fig. 3B ).
The marked coexpression of Smad6 and Smad7 described above was not universal as demonstrated in a comparative analysis of Smad3, Smad4, Smad6, and Smad7 expression in selected tissues (Fig. 4) . The trigeminal ganglion at E15 (Fig. 4A) contains low or undetectable Smad3 (also true for other peripheral ganglia), but high Smad4 throughout. Smad7 is high, but appears as a punctate signal suggesting expression in selected cells. Smad6 expression is even more restricted to a small number of cells in the trigeminal ganglion.
A second tissue with an interesting expression pattern was developing bones (Fig. 4B) . Both Smad6 and Smad7 were expressed in bones undergoing endochondral ossi®ca-tion, whereas Smad6 was selectively expressed in intramembranous bones shown for the mandibular bone delineated by arrowheads in Fig. 4B as well as for the palatal bone indicated by arrow in Fig. 4A . Also Smad3 was elevated in developing intramembranous bones, whereas Smad4 was ubiquitously expressed.
In the digestive tract unspeci®c expression of several of the Smad genes earlier in development was contrasted by a shift to mucosal epithelium at E15 for Smad4, Smad6,and Smad7 (Fig. 4C ). There Smad4 was speci®cally expressed in mucosal crypts, and Smad6 and Smad7 throughout the epithelium.
The developing testis with ubiquitous Smad3 and Smad4 displayed a striking expression pattern with Smad6 and Smad7 (Fig. 4D) . Smad7 was selectively expressed in the seminiferous tubules whereas Smad6 transcripts were con®ned to the gonadal mesentery. Both genes showed high signal in the mesenchyme around the Mu Èllerian duct while Smad6 signal was absent in Wolf®an duct.
Materials and methods
Mouse ESTs, Smad3 (IMAGE n:o 456861, insert size about 0.75 kbp), Smad4 (n:o 466551, about 2.2 kbp), Smad5 (n:o 619816, about 0.6 kbp), Smad6 (850294, about 1 kbp) and mouse Flag-Smad7 (about 1.3 kbp; a kind gift from Dr Jeff Wrana and Professor Liliana Attisano, University of Toronto, Canada) were used in in situ hybridization (Wilkinson and Green, 1990) . Fig. 1 . Expression of Smad3, Smad5, Smad6, and Smad7 in sagittal sections of E9 and E10 embryos as indicated using bright®eld (A) or dark®eld (B±F) illumination. In E10 embryos Smad7 show widespread expression outside the developing central nervous system. A marked expression is seen in dorsal aorta (a). Abbreviations: a, dorsal aorta; as, aortic sac; ba, ®rst branchial arch; bc, bulbus cordis; fb, forebrain; h, heart; hb, hindbrain; l, limb; m, medial nasal process; mb, midbrain; me, marginal neuroepithelium; nt, neural tube; s, somite. Scale bar: 250 mm. Bar in (D) applies to (A± D). All sections were exposed for 3 weeks. Fig. 2 . Expression of Smad3, Smad4, Smad5, Smad6, and Smad7 in E12 embryos. Abbreviations: a, dorsal aorta; cp, choroid plexus; d, duodenum; dg, diaphragma; fb, forebrain; fp,¯oor plate; h, heart; hb, hindbrain; l, liver; lg, lung; m, meninge; ma, mesenteric artery; mb, midbrain; md, mandibular process; mx, maxillary process; n, nasal cavity; ne, neuroepithelium; o, otic vesicle; p, pulmonary trunk; pg, pituitary gland; sc, spinal cord, u, urethra; ve, ventricle. Scale bar: 1 mm. Fig. 3 . Expression of Smad3 and Smad6 in E14 embryos. Abbreviations: a, aorta; cp, choroid plexus; d, duodenum; e, endocardium; f, femur; l, liver; lg, lung; ma, mesenteric artery; mdb, mandibular bone; mxb, maxillary bone; nb, nasal bone; ne, neuroepithelium, o, ovary; r, rib; ra, right atrium; sc, spinal cord; sg, submandibular salivary gland; t, tongue; u, urogenital sinus. Scale bars: 1 mm. Fig. 4 . Comparative analysis of Smad3, Smad4, Smad6 and Smad7 expression in developing trigeminal ganglia (A), mandible (B), midgut (C) and testis (D). Arrow in (A) indicates ossifying palatal bone. In (B) arrows indicate outer dental epitheliun of incisive tooth germ and arrowheads delineate the ossifying mandibular bone. In (D) the asterisk indicates seminiferous tubules and arrows the Mu Èllerian duct and arrowheads the Wolf®an duct. Abbreviations: i, dental mesenchyme; kd, metanephic kidney; mc, Meckel's cartilage; me, mucosal epithelium; tg, trigeminal ganglion. Scale bars: 200 mm.
